G K Dy
Overview
Explore the profile of G K Dy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramnath N, Daignault-Newton S, Dy G, Muindi J, Adjei A, Elingrod V, et al.
Cancer Chemother Pharmacol
. 2013 Feb;
71(5):1173-82.
PMID: 23435876
Background: Preclinical studies demonstrated antiproliferative synergy of 1,25-D3 (calcitriol) with cisplatin. The goals of this phase I/II study were to determine the recommended phase II dose (RP2D) of 1,25-D3 with...
2.
Dy G, Miller A, Mandrekar S, Aubry M, Langdon Jr R, MORTON R, et al.
Ann Oncol
. 2005 Aug;
16(11):1811-6.
PMID: 16087693
Background: The aim of the present study was to evaluate the clinical activity of imatinib mesylate in patients with recurrent and refractory c-kit-expressing small-cell lung cancer. Patients And Methods: Patients...
3.
Haluska P, Dy G, Adjei A
Eur J Cancer
. 2002 Aug;
38(13):1685-700.
PMID: 12175684
Protein farnesylation catalysed by the enzyme farnesyl protein transferase involves the addition of a 15-carbon farnesyl group to conserved amino acid residues at the carboxyl terminus of certain proteins. Protein...
4.
Dy G, Haluska P, Adjei A
Expert Opin Investig Drugs
. 2002 Jan;
10(12):2059-88.
PMID: 11772306
For decades, cancer therapy has focused on DNA-directed mechanisms of cytotoxicity, utilising agents with limited efficacy and significant toxicity. Recent advances in tumour biology have elucidated the molecular pathways implicated...